Nothing Special   »   [go: up one dir, main page]

Wang et al., 2021 - Google Patents

Prenatal exposure to mercury and precocious puberty: a prospective birth cohort study

Wang et al., 2021

View HTML
Document ID
16053874248374811936
Author
Wang G
Tang W
Ji H
Wang X
Publication year
Publication venue
Human reproduction

External Links

Snippet

STUDY QUESTION Is in utero exposure to mercury associated with the risk of precocious puberty? SUMMARY ANSWER Prenatal exposure to high levels of mercury was associated with increased risk of precocious puberty, which was strengthened by concomitant maternal …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Similar Documents

Publication Publication Date Title
Wang et al. Prenatal exposure to mercury and precocious puberty: a prospective birth cohort study
Kristensen et al. Long-term effects of prenatal exposure to perfluoroalkyl substances on female reproduction
Sugiura-Ogasawara et al. Exposure to bisphenol A is associated with recurrent miscarriage
Varimo et al. Congenital hypogonadotropic hypogonadism, functional hypogonadotropism or constitutional delay of growth and puberty? An analysis of a large patient series from a single tertiary center
Lie Fong et al. Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood
Thomas-Teinturier et al. Ovarian reserve after treatment with alkylating agents during childhood
Fei et al. Maternal levels of perfluorinated chemicals and subfecundity
Thankamony et al. Higher levels of IGF-I and adrenal androgens at age 8 years are associated with earlier age at menarche in girls
Ernst et al. Maternal smoking during pregnancy and reproductive health of daughters: a follow-up study spanning two decades
Chang et al. Phthalates might interfere with testicular function by reducing testosterone and insulin-like factor 3 levels
Busch et al. Dynamic changes of reproductive hormones in male minipuberty: temporal dissociation of Leydig and Sertoli cell activity
Rose et al. Endocrine phenotype of children and adults with Fanconi anemia
Jaquet et al. Intrauterine growth retardation predisposes to insulin resistance but not to hyperandrogenism in young women
Chaoimh et al. Cord blood leptin and gains in body weight and fat mass during infancy
Keglberg Hærvig et al. Fetal Programming of Semen Quality (FEPOS) cohort–a DNBC male-offspring cohort
Deodati et al. Serum levels of polybrominated diphenyl ethers in girls with premature thelarche
Lambert-Messerlian et al. First assessment of menstrual cycle function and reproductive endocrine status in Samoan women
van Welie et al. Thyroid function in neonates conceived after hysterosalpingography with iodinated contrast
Harlow et al. Per-and polyfluoroalkyl substances and hormone levels during the menopausal transition
González-Foruria et al. Clinically significant intra-day variability of serum progesterone levels during the final day of oocyte maturation: a prospective study with repeated measurements
Corsonello et al. A cross-section analysis of FT3 age-related changes in a group of old and oldest-old subjects, including centenarians’ relatives, shows that a down-regulated thyroid function has a familial component and is related to longevity
Merino et al. High DHEAS level in girls is associated with earlier pubertal maturation and mild increase in androgens throughout puberty without affecting postmenarche ovarian morphology
Ljubicic et al. The LH/FSH ratio is not a sex-dimorphic marker after infancy: data from 6417 healthy individuals and 125 patients with Differences of Sex Development
Cai et al. Maternal hyperglycemia in singleton pregnancies conceived by IVF may be modified by first-trimester BMI
Kakleas et al. Gastric autoimmunity in children and adolescents with type 1 diabetes: a prospective study